Access to Chiral <i>O</i>,<i>O</i>‐Acetals Enabled by Palladium‐Catalyzed Asymmetric Addition of Oximes to Alkoxyallenes
作者:Zhuo‐Wei Xu、Shaozhong Wang
DOI:10.1002/chem.202301883
日期:2023.11.21
A palladium-catalyzed chemo-, regio- and stereoselective coupling of oximes and alkoxy allenes enables the access to enantiomerically pure O,O-acetals, in which the hydrogen bonding interaction between the amide group of the diphosphine ligand and the alkoxy allene is decisive for the high enantioselectivity.
钯催化的肟和烷氧基丙二烯的化学、区域和立体选择性偶联能够获得对映体纯的O , O -缩醛,其中二膦配体的酰胺基团和烷氧基丙二烯之间的氢键相互作用对于高对映选择性。
Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor
作者:Jeff DeFalco、Daniel Steiger、Amy Gustafson、Daniel E. Emerling、Michael G. Kelly、Matthew A.J. Duncton
DOI:10.1016/j.bmcl.2009.10.113
日期:2010.1
AP18 1 was recently disclosed as an antagonist of the TRPA1 receptor by the research group of Patapoutian. However, no detailed structure-activity relationships around 1 have been disclosed. Thus, a small number of oximes related to AP18 were examined in order to characterize the determinants of TRPA1 activity. Congeners of AP18 were found to possess both agonist and antagonist activity, suggesting that AP18 may behave as a covalent antagonist of the TRPA1 ion-channel. (c) 2009 Elsevier Ltd. All rights reserved.
PEAKE, C. J.;STRICKLAND, J. H., SYNTH. COMMUN., 1986, 16, N 7, 763-765
作者:PEAKE, C. J.、STRICKLAND, J. H.
DOI:——
日期:——
USE OF TRPA1 ANTAGONISTS TO PREVENT OR TREAT INFECTIONS CAUSED BY BIOLOGICAL-WARFARE AGENTS
申请人:HYDRA BIOSCIENCES, INC.
公开号:US20170151248A1
公开(公告)日:2017-06-01
Provided are methods for preventing and treating injuries caused by exposure to biological warfare agents. The methods include administering to a subject in need thereof an effective amount of a TRPA1 antagonist or a pharmaceutically acceptable salt thereof. In an embodiment the TRPA1 antagonist is selected from the group consisting of compounds of formula I
and compounds of formula II
as described herein.